These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18040783)

  • 1. Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.
    Bell JE; Arango JC; Anthony IC
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):182-91. PubMed ID: 18040783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.
    Buckner CM; Luers AJ; Calderon TM; Eugenin EA; Berman JW
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):160-81. PubMed ID: 18040782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of HIV.
    Hult B; Chana G; Masliah E; Everall I
    Int Rev Psychiatry; 2008 Feb; 20(1):3-13. PubMed ID: 18240058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmunity, drugs of abuse, and neuroAIDS.
    Burdo TH; Katner SN; Taffe MA; Fox HS
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):41-9. PubMed ID: 18040790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?
    Anthony IC; Ramage SN; Carnie FW; Simmonds P; Bell JE
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):325-38. PubMed ID: 15885069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.
    Kaul M; Lipton SA
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):138-51. PubMed ID: 18040780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.
    Smith DB; Simmonds P; Bell JE
    J Neurovirol; 2014 Feb; 20(1):28-38. PubMed ID: 24420447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 associated dementia: symptoms and causes.
    Ghafouri M; Amini S; Khalili K; Sawaya BE
    Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does drug abuse influence the microglial response in AIDS and HIV encephalitis?
    Arango JC; Simmonds P; Brettle RP; Bell JE
    AIDS; 2004 Jan; 18 Suppl 1():S69-74. PubMed ID: 15075500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.
    Grovit-Ferbas K; Harris-White ME
    Immunol Res; 2010 Dec; 48(1-3):40-58. PubMed ID: 20725864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When do models of NeuroAIDS faithfully imitate "the real thing"?
    Gelman BB; Endsley J; Kolson D
    J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
    Cai Y; Yang L; Callen S; Buch S
    Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neuropathology of HIV/AIDS.
    Anthony IC; Bell JE
    Int Rev Psychiatry; 2008 Feb; 20(1):15-24. PubMed ID: 18240059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropathogenesis of AIDS.
    González-Scarano F; Martín-García J
    Nat Rev Immunol; 2005 Jan; 5(1):69-81. PubMed ID: 15630430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of human immunodeficiency virus in the central nervous system.
    Kolson DL; Lavi E; González-Scarano F
    Adv Virus Res; 1998; 50():1-47. PubMed ID: 9520995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
    Vissers M; Stelma FF; Koopmans PP
    J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
    Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
    J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
    Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
    Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.